MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 103 filers reported holding MIRUM PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $7,013 | +29.6% | 221,946 | +6.1% | 0.01% | +42.9% |
Q2 2023 | $5,413 | +1760.1% | 209,252 | +1629.6% | 0.01% | – |
Q1 2023 | $291 | +33.5% | 12,098 | +8.4% | 0.00% | – |
Q4 2022 | $218 | -99.9% | 11,165 | -0.1% | 0.00% | – |
Q3 2022 | $235,000 | +9.3% | 11,173 | +1.2% | 0.00% | – |
Q2 2022 | $215,000 | +571.9% | 11,042 | +661.5% | 0.00% | – |
Q1 2022 | $32,000 | -63.2% | 1,450 | -73.4% | 0.00% | – |
Q4 2021 | $87,000 | -20.2% | 5,450 | 0.0% | 0.00% | – |
Q3 2021 | $109,000 | +16.0% | 5,450 | -0.2% | 0.00% | – |
Q2 2021 | $94,000 | -12.1% | 5,462 | +0.9% | 0.00% | – |
Q1 2021 | $107,000 | +13.8% | 5,412 | 0.0% | 0.00% | – |
Q4 2020 | $94,000 | -9.6% | 5,412 | 0.0% | 0.00% | – |
Q3 2020 | $104,000 | +70.5% | 5,412 | +73.9% | 0.00% | – |
Q2 2020 | $61,000 | +165.2% | 3,112 | +93.1% | 0.00% | – |
Q1 2020 | $23,000 | -42.5% | 1,612 | 0.0% | 0.00% | – |
Q4 2019 | $40,000 | -32.2% | 1,612 | -72.7% | 0.00% | – |
Q3 2019 | $59,000 | – | 5,912 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Frazier Life Sciences Management, L.P. | 6,470,392 | $204,464,387 | 13.58% |
NEA Management Company, LLC | 2,186,243 | $69,085,279 | 5.34% |
TANG CAPITAL MANAGEMENT LLC | 1,137,107 | $35,932,581 | 5.07% |
BOONE CAPITAL MANAGEMENT LLC | 389,791 | $12,317,396 | 3.89% |
Highlander Partners, L.P. | 122,980 | $3,886,168 | 3.84% |
BVF INC/IL | 4,370,024 | $138,092,758 | 3.72% |
Prosight Management, LP | 353,508 | $11,170,853 | 3.54% |
Novo Holdings A/S | 1,500,000 | $47,400,000 | 3.50% |
Nicholas Investment Partners, LP | 1,199,366 | $37,899,966 | 2.83% |
Eventide Asset Management | 3,958,579 | $125,091,097 | 2.25% |